SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-009523
Filing Date
2022-05-31
Accepted
2022-05-31 08:55:38
Documents
12
Period of Report
2022-05-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220524x8k.htm   iXBRL 8-K 34912
  Complete submission text file 0001558370-22-009523.txt   155721

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20220524.xsd EX-101.SCH 3063
3 EX-101.LAB tmb-20220524_lab.xml EX-101.LAB 16021
4 EX-101.PRE tmb-20220524_pre.xml EX-101.PRE 10428
6 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220524x8k_htm.xml XML 4854
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 22980776
SIC: 2834 Pharmaceutical Preparations